Third-generation fluoroquinolones may not pose the same risk to tendon health as earlier-generation agents, the findings of a new study suggest.
If confirmed, this will be good news for patients who are allergic to beta-lactam antibiotics and others in whom fluoroquinolones are the antibiotics of choice because of their favorable pharmacokinetic properties and broad-spectrum activity, according to Takashi Chinen of Jichi Medical University in Tochigi, Japan, lead investigator of the new study, published in Annals of Family Medicine.
"This is especially notable for patients who are at increased risk for tendon disorders, such as athletes," Chinen said in an interview.
To investigate the association between third-generation fluoroquinolones and tendinopathy, Chinen and colleagues conducted a self-controlled case series analysis using administrative claims data for a single prefecture in Japan, focusing specifically on the risk of Achilles tendon rupture.
Read more here : https://www.medscape.com/viewarticle/950957?src=WNL_mdpls_210514_mscpedit_fmed&uac=218819SG&spon=34&impID=3373972&faf=1
Comments